{
    "nctId": "NCT01768195",
    "officialTitle": "Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy",
    "inclusionCriteria": "* treatment-naive patients with B-cell lymphoma\n* HBsAg positive at baseline\n* treated with rituximab-based immunochemotherapy\n* life expectancy of more than 3 months\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* younger than 18 years old\n* HBsAg negative at baseline\n* pregnant or lactating women"
}